Global Oncolytic Virus Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Oncolytic Virus Therapy Market Overview

• 1.1 Product Overview and Scope of Oncolytic Virus Therapy
• 1.2 Classification of Oncolytic Virus Therapy by Type
  • 1.2.1 Global Oncolytic Virus Therapy Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019
  • 1.2.3 HSV-based Oncolytic Viruses
  • 1.2.4 Adenoviruses-based Oncolytic Viruses
  • 1.2.5 Vaccinia Virus-based Oncolytic Viruses
  • 1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
  • 1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
• 1.3 Global Oncolytic Virus Therapy Market by Application
  • 1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Melanoma
  • 1.3.3 Prostate Cancer
  • 1.3.4 Breast Cancer
  • 1.3.5 Ovarian Cancer
  • 1.3.6 Others
• 1.4 Global Oncolytic Virus Therapy Market by Regions
  • 1.4.1 Global Oncolytic Virus Therapy Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Amgen
  • 2.1.1 Amgen Details
  • 2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Amgen SWOT Analysis
  • 2.1.4 Amgen Product and Services
  • 2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 SillaJen Biotherapeutics
  • 2.2.1 SillaJen Biotherapeutics Details
  • 2.2.2 SillaJen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 SillaJen Biotherapeutics SWOT Analysis
  • 2.2.4 SillaJen Biotherapeutics Product and Services
  • 2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Transgene SA
  • 2.3.1 Transgene SA Details
  • 2.3.2 Transgene SA Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Transgene SA SWOT Analysis
  • 2.3.4 Transgene SA Product and Services
  • 2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Oncolytics Biotech
  • 2.4.1 Oncolytics Biotech Details
  • 2.4.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Oncolytics Biotech SWOT Analysis
  • 2.4.4 Oncolytics Biotech Product and Services
  • 2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 PsiOxus Therapeutics
  • 2.5.1 PsiOxus Therapeutics Details
  • 2.5.2 PsiOxus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 PsiOxus Therapeutics SWOT Analysis
  • 2.5.4 PsiOxus Therapeutics Product and Services
  • 2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Viralytics
  • 2.6.1 Viralytics Details
  • 2.6.2 Viralytics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Viralytics SWOT Analysis
  • 2.6.4 Viralytics Product and Services
  • 2.6.5 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Lokon Pharma
  • 2.7.1 Lokon Pharma Details
  • 2.7.2 Lokon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Lokon Pharma SWOT Analysis
  • 2.7.4 Lokon Pharma Product and Services
  • 2.7.5 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Targovax
  • 2.8.1 Targovax Details
  • 2.8.2 Targovax Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Targovax SWOT Analysis
  • 2.8.4 Targovax Product and Services
  • 2.8.5 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Oncolys BioPharma
  • 2.9.1 Oncolys BioPharma Details
  • 2.9.2 Oncolys BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Oncolys BioPharma SWOT Analysis
  • 2.9.4 Oncolys BioPharma Product and Services
  • 2.9.5 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Sorrento Therapeutics
  • 2.10.1 Sorrento Therapeutics Details
  • 2.10.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Sorrento Therapeutics SWOT Analysis
  • 2.10.4 Sorrento Therapeutics Product and Services
  • 2.10.5 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Genelux Corporation
  • 2.11.1 Genelux Corporation Details
  • 2.11.2 Genelux Corporation Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Genelux Corporation SWOT Analysis
  • 2.11.4 Genelux Corporation Product and Services
  • 2.11.5 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Cold Genesys
  • 2.12.1 Cold Genesys Details
  • 2.12.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Cold Genesys SWOT Analysis
  • 2.12.4 Cold Genesys Product and Services
  • 2.12.5 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Vyriad
  • 2.13.1 Vyriad Details
  • 2.13.2 Vyriad Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Vyriad SWOT Analysis
  • 2.13.4 Vyriad Product and Services
  • 2.13.5 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 TILT Biotherapeutics
  • 2.14.1 TILT Biotherapeutics Details
  • 2.14.2 TILT Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 TILT Biotherapeutics SWOT Analysis
  • 2.14.4 TILT Biotherapeutics Product and Services
  • 2.14.5 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share
  • 3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions
• 4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5 North America Oncolytic Virus Therapy Revenue by Countries

• 5.1 North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)
• 5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6 Europe Oncolytic Virus Therapy Revenue by Countries

• 6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2015-2020)
• 6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries

• 7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2015-2020)
• 7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

8 South America Oncolytic Virus Therapy Revenue by Countries

• 8.1 South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)
• 8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries

• 9.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2015-2020)
• 10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2019-2024)
• 10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
• 10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
• 10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
• 10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
• 10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

11 Global Oncolytic Virus Therapy Market Segment by Application

• 11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2015-2020)
• 11.2 Oncolytic Virus Therapy Market Forecast by Application (2019-2024)
• 11.3 Melanoma Revenue Growth (2015-2020)
• 11.4 Prostate Cancer Revenue Growth (2015-2020)
• 11.5 Breast Cancer Revenue Growth (2015-2020)
• 11.6 Ovarian Cancer Revenue Growth (2015-2020)
• 11.7 Others Revenue Growth (2015-2020)

12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

• 12.1 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)
• 12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2021-2025)
• 12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
• 12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
• 12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer